Senior Director Global Oncology Heor

**Passion for Innovation. Compassion for Patients.**:
**Senior Director Global Oncology HEOR & RWE (M/F/x)**:
**Purpose**:
The purpose of this role is to develop and drive the Global HEOR and RWE strategies for the assigned oncology franchise products, in alignment with key global and regional functions. The Global Sr Director of HEOR & RWE Oncology will lead the HEOR and RWE asset team in the execution of the market access strategy and evidence generation activities across Daiichi-Sankyo. He/She will build and drive the asset specific HEOR strategy and coordinate all corresponding HEOR and RWE activities under the Global Oncology Value Access & Pricing department for the Oncology Business Unit, in collaboration with cross-functional teams. The role will be responsible for the HEOR and RWE strategy and tactical plans, including decision making and people management in the conduct of global health economic models, global value dossiers, RWE studies, PRO analysis, and will develop plans for innovative tools, methods, and strategies to ensure successful market access and support the company’s vision of being a leader in oncology and deliver the innovative Daiichi Sankyo’s treatments to patient. The Sr Director will direct and supervise evidence generation strategies and tactics, both through cross-functional teams and management of subordinates.

***Relationships**:
Reports directly to the Vice President and Global Head of Oncology HEOR and RWE and has the responsibility to build a robust global HEOR/RWE strategy and manage team members and resources in order to execute on the strategy. The position will be a key and visible expert leader, he/she will engage the clinical, Medical Affairs and commercial organization and drive the product evidence strategies to ensure an effective use of HEOR and RWE methods. The Sr Director will provide HEOR and RWE strategic direction to Global Project Teams (GPTs) and Global Brand Teams (GBTs) and provide recommendations on such aspects as appropriate comparators, target patient populations, clinical and economic endpoints and patient-reported outcomes (PROs), ensuring the payer perspective is incorporated in the assigned clinical development programs and the evidence needed to support optimal market access is addressed. The Sr Director will help set up new strategies for the company and the HEOR team that will ensure a successful launch our oncology products. Lead the team through direct line management and arrange cross-functional working teams to drive process improvements and efficiencies. Furthermore, the role will develop HEOR sections in target product profiles (TPPs), product development plans, clinical development plans, and commercialization plans and other critical documents.

**Essential Functions**:

- The Global Sr Director of Oncology HEOR and RWE will have responsibility and accountability for the following:

- Lead the team in the preparation of global value dossiers which present the product value propositions and the supporting evidence, aligned with the product development strategies and agreed/endorsed by the GPTs, GBTs, Regional HEOR and market access, to realize an optimal value demonstration of the products
- Supervise the conduct of HEOR and RWE studies such as early economic models, burden of illness studies, external control arms to support single arm trials, and drive the development, analysis, and validation of patient-reported outcome (PRO) instruments in clinical trials
- Oversee the implementation of literature reviews to build payer evidence, economic models, and Global Value Dossiers
- Propose and drive the implementation of analysis of clinical trial data for cost effectiveness models and market specific ad-hoc requests for reimbursement submissions
- Assess RWE data gaps and building cross-functional evidence generation strategy for payers and reimbursement submissions
- Direct and oversee the implementation of global cost effectiveness and budget impact models for HTA submissions to support reimbursement of indications for Daiichi Sankyo’s oncology products
- Decide on HEOR and RWE communications (e.g. manuscripts, scientific forum presentations, slide decks, symposia), in collaboration with multi-functional teams, to build the peer reviewed published evidence supporting the value propositions for assigned products
- Effectively manage external consultancies and contractors, ensuring delivery according to key milestones, budget and to agreed and expected quality
- Maintain and continue to enhance knowledge about HEOR methods and the evolving public health policy and reimbursement environment in major (USA, Europe and Japan) and other pertinent markets
- Direct the team to ensure cross-functional collaboration between Global Value Access and Pricing and other internal stakeholders such as Medical Affairs, Clinical Development, Marketing, Biostats, etc.

**Qualifications**:

- Doctorate or Master’s degree in a relevant discipline (e.